Ligand Pharmaceuticals (NasdaqGM:LGND) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnnabel Samimy - Managing DirectorJoe Pantginis - Managing DirectorJoohwan Kim - Assistant VP of BiotechnologyLauren Hay - VP of Strategic Planning and Investment AnalyticsMelanie Herman - Executive Director of Investor RelationsTavo Espinoza - CFOTodd Davis - CEOConference Call ParticipantsJohn Vandermosten - Senior AnalystMatt Hewitt - Senior Research AnalystPete Lucas - AnalystTrevor Allred - Ex ...

Cronos Group (NasdaqGM:CRON) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnna Shlimak - CFOHarrison Aaron - Senior Director of Investor Relations and Corporate DevelopmentMike Gorenstein - Chairman, President, and CEORyan Neal - Equity Research AssociateConference Call ParticipantsBill Kirk - Managing Director and Senior Research AnalystKendrick Tai - Equity Research Analyst of Cannabis and Consumer GrowthPablo Zuanic - Founder, Managing Partner, and Equity Research Analyst of Ca ...

argenx (NasdaqGS:ARGX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAkash Tewari - Global Head of Biopharmaceutical ResearchAlex Thompson - Managing DirectorBeth DelGiacco - VP of Corporate AffairsDanielle Brill - Managing DirectorDouglas Tsao - Managing DirectorJames Gordon - Director and Head of European PharmaJustin Smith - DirectorKaren Massey - COOKarl Gubitz - CFOLuc Truyen - Chief Medical OfficerMatt Phipps - Partner and Group Head of BiotechnologyRajan Sharma - Executive D ...

Thryv (NasdaqCM:THRY) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsCameron Lessard - VP of Corporate Development and StrategyJoe Walsh - Chairman and CEOMatthew Swanson - Director of Equity ResearchPaul Rouse - CFOSean Wechter - CTOConference Call ParticipantsArjun Bhatia - Partner and Software Research AnalystJason Kreyer - Senior Research AnalystZach Cummins - Senior Research AnalystOperatorLadies and gentlemen, thank you for joining us, welcome to the Thryv fourth quarter 2025 ...

Ligand Pharmaceuticals (NasdaqGM:LGND) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnnabel Samimy - Managing DirectorJoe Pantginis - Managing DirectorJoohwan Kim - Assistant VP of BiotechnologyLauren Hay - VP of Strategic Planning and Investment AnalyticsMelanie Herman - Executive Director of Investor RelationsTavo Espinoza - CFOTodd Davis - CEOConference Call ParticipantsJohn Vandermosten - Senior AnalystMatt Hewitt - Senior Research AnalystPete Lucas - AnalystTrevor Allred - Ex ...

Vericel (NasdaqGM:VCEL) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsEric Burns - VP of Finance and Investor RelationsJeffrey Cohen - Managing Director and Director of Equity ResearchJoe Mara - CFOJosh Jennings - Managing DirectorNick Colangelo - President and CEOConference Call ParticipantsMason Carrico - Research AnalystRyan Zimmerman - Managing Director and Medical Technology AnalystSwayampakula Ramakanth - Managing Director and Senior Healthcare AnalystNone - AnalystNone - Ana ...

Nautilus Biotechnology (NasdaqGS:NAUT) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnna Mowry - CFOJi-Yon Yi - Director of Investor RelationsParag Mallick - Co-founder and Chief ScientistSujal Patel - Co-founder and CEOConference Call ParticipantsSubhasis Nambi - Equity Research AnalystNone - AnalystOperatorGood day, and thank you for standing by. Welcome to the Nautilus Biotechnology Q4 2025 earnings conference call. At this time, all participants are in a listen-only mode. Afte ...

Shenandoah Telecommunications Company (NasdaqGS:SHEN) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsEd McKay - President and CEOHamed Khorsand - PrincipalJim Volk - SVP and CFOLucas Binder - Vice President of Corporate FinanceVikash Harlalka - Director on U.S. Communication ServicesOperatorThank you for standing by. My name is Liz, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Shenandoah Telecommunications Company Fourth Quarter 2025 ...

USA TODAY (NYSE:GCI) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsGiuliano Bologna - Managing DirectorKristin Roberts - PresidentMatt Condon - Director Equity Research of Internet and Digital MediaMatt Esposito - Head of Investor RelationsMike Reed - Chairman and CEOTrisha Gosser - CFOConference Call ParticipantsBarton Crockett - Managing Director and Senior Research AnalystOperatorGreetings! Welcome to the USA TODAY Co., Inc. Q4 2025 earnings call. At this time, all participants ...

Arhaus (NasdaqGS:ARHS) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsJohn Reed - Founder, Chairman, and CEOJonathan Matuszewski - SVP of Equity ResearchMichael Lee - CFOTara Atwood-Saja - VP of Investor RelationsConference Call ParticipantsPedro Gil - Equity Research AnalystSeth Sigman - Managing Director and Senior Equity Research AnalystSteven Forbes - Senior Managing Director and Equity Research AnalystOperatorGood morning. Welcome to the Arhaus fourth quarter and full year 2025 ...